Next Article in Journal
Physically and Chemically Crosslinked, Tannic Acid Embedded Linear PEI-Based Hydrogels and Cryogels with Natural Antibacterial and Antioxidant Properties
Next Article in Special Issue
Cell-Free Supernatant Derived from a Lactobacillus casei BL23 Culture Modifies the Antiviral and Immunomodulatory Capacity of Mesenchymal Stromal Cells
Previous Article in Journal
The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer
Previous Article in Special Issue
Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing
 
 
Review
Peer-Review Record

Gut Microbiota, LADA, and Type 1 Diabetes Mellitus: An Evolving Relationship

Biomedicines 2023, 11(3), 707; https://doi.org/10.3390/biomedicines11030707
by Andrea Piccioni 1, Federico Rosa 2,*, Sergio Mannucci 2, Federica Manca 2, Giuseppe Merra 3, Sabrina Chiloiro 1,4, Marcello Candelli 1, Marcello Covino 1,2, Antonio Gasbarrini 1,2 and Francesco Franceschi 1,2
Reviewer 1:
Reviewer 2:
Biomedicines 2023, 11(3), 707; https://doi.org/10.3390/biomedicines11030707
Submission received: 1 January 2023 / Revised: 14 February 2023 / Accepted: 21 February 2023 / Published: 25 February 2023

Round 1

Reviewer 1 Report

- Please write the name of figures below the figure

- Discussion should be rewritten to sounds good

- Conclusion needs to be more comprehensive with more details 

Author Response

- Please write the name of figures below the figure

We did it

- Discussion should be rewritten to sounds good

We did it

- Conclusion needs to be more comprehensive with more details 

We did it

Thank you very much for your advice, we have improved our paper and are available for any new suggestions.

Reviewer 2 Report

This review is very interesting, but in this form confusing to me.

First I miss a glossary. In line 137 FMT is used and not explained that happens in line 282. It looks as if different authors has written different parts.

And especial the part on Fecal microbiota transplantation as treatment for Type 1 diabetes mellitus is confusing to me. At line 162 the sentence starts with “Our primary endpoint etc. Who are the “OUR” or is this sentence  “cut and paste” from another place ???

And line 192. T1d is used without explanation. So especially this important  part  3.4 .  of the paper has to be improved.

What is also confusing is that the number of the reference is after the point, it should be before. Now it gives the impression that the reference belongs to the sentence coming.

Again the subject is very interesting but the paper must be improved.

Author Response

This review is very interesting, but in this form confusing to me.

First I miss a glossary.

-We added it.

 In line 137 FMT is used and not explained that happens in line 282. It looks as if different authors has written different parts.

And especial the part on Fecal microbiota transplantation as treatment for Type 1 diabetes mellitus is confusing to me. At line 162 the sentence starts with “Our primary endpoint etc. Who are the “OUR” or is this sentence  “cut and paste” from another place ???

-We correct it

And line 192. T1d is used without explanation. So especially this important  part  3.4 .  of the paper has to be improved.

What is also confusing is that the number of the reference is after the point, it should be before. 

Now it gives the impression that the reference belongs to the sentence coming.

-We correct it

Again the subject is very interesting but the paper must be improved.

-Thank you very much for your advice, we have improved our paper and are available for any new suggestions.

Round 2

Reviewer 2 Report

The article can be accepted, thank you for the corrections. 

Author Response

Thank you for your valuable suggestions, best regards

Back to TopTop